Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France flag France · Delayed Price · Currency is EUR
0.3420
+0.0010 (0.29%)
At close: Jun 23, 2026

EPA:ALOPM Balance Sheet

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
0.310.440.3213.37
Short-Term Investments
1.84.8410.01-
Cash & Short-Term Investments
2.115.2710.3413.37
Cash Growth
-59.89%-48.99%-22.72%-
Accounts Receivable
0.340.621.060.48
Other Receivables
0.222.32.682.41
Receivables
0.562.923.742.89
Inventory
10.47---
Prepaid Expenses
0.140.460.320.14
Other Current Assets
-0--
Total Current Assets
13.288.6614.416.41
Property, Plant & Equipment
0.50.630.760.9
Long-Term Investments
0.040.080.06-
Other Intangible Assets
1.051.081.150.79
Other Long-Term Assets
0.120.260.260.27
Total Assets
14.9910.7116.6318.37
Accounts Payable
1.452.242.892.98
Accrued Expenses
1.27---
Short-Term Debt
0.03---
Current Portion of Long-Term Debt
4.31---
Current Income Taxes Payable
0.030.851.190.98
Current Unearned Revenue
0.03---
Other Current Liabilities
0.01---
Total Current Liabilities
7.133.094.083.96
Long-Term Debt
2.057.588.832.6
Long-Term Unearned Revenue
-0.130.03-
Other Long-Term Liabilities
0.010.3400.02
Total Liabilities
9.1811.1412.946.59
Common Stock
1.856.225.75.68
Additional Paid-In Capital
0.095.594.374.39
Retained Earnings
-0.06-15.53-8.32-0.23
Comprehensive Income & Other
3.923.291.941.94
Shareholders' Equity
5.8-0.433.6911.78
Total Liabilities & Equity
14.9910.7116.6318.37
Total Debt
6.387.588.832.6
Net Cash (Debt)
-4.27-2.311.5110.77
Net Cash Growth
---85.98%-
Net Cash Per Share
-0.23-0.130.090.65
Filing Date Shares Outstanding
19.0418.1716.6616.59
Total Common Shares Outstanding
18.4518.1716.6316.59
Working Capital
6.165.5710.3212.45
Book Value Per Share
0.31-0.020.220.71
Tangible Book Value
4.76-1.512.5410.99
Tangible Book Value Per Share
0.26-0.080.150.66
Land
0.110.110.110.11
Buildings
0.250.250.250.24
Machinery
0.880.880.860.86